SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Human & Experimental Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Torres-Alanís, O
Right arrow Articles by Piñeyro-López, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Torres-Alanís, O
Right arrow Articles by Piñeyro-López, A
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Effect of meso-2,3-dimercaptosuccinic acid on urinary lead excretion in exposed men

O Torres-Alanís

Centro Antivenenos, Departamento de Farmacología y Toxicología, Facultad de Medicina, Universidad Autónoma de Nuevo León, Apartado Postal 146, Col. del Valle, Monterrey, Nuevo León, México; otorres{at}ccr.dsi.uanl.mx

L Garza-Ocañas

A Piñeyro-López

Centro Antivenenos, Departamento de Farmacología y Toxicología, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México

The efficacy of meso-2,3-dimercaptosuccinic acid (DMSA) was evaluated in workers occupationally exposed to lead (Pb; blood level >50 mg //dL). Ten men were given 600 mg of DMSA per orem daily, for five days. Pb concentrations of whole blood and urine were determined throughout therapy. Hematology analyses, blood chemistry, and urinalysis were obtained at the start of the study, at the end of the DMSA treatment, and at 72 hours after the administration of the final dose. DMSA therapy had no influence on hepatic, hematologic, or renal functions and was effective in decreasing the concentration of blood Pb in all the subjects without adverse drug reactions.

Key Words: DMSA • lead • occupational exposure

Human & Experimental Toxicology, Vol. 21, No. 11, 573-577 (2002)
DOI: 10.1191/0960327102ht280oa
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 QJMHome page
S. Bradberry, T. Sheehan, and A. Vale
Use of oral dimercaptosuccinic acid (succimer) in adult patients with inorganic lead poisoning
QJM, October 1, 2009; 102(10): 721 - 732.
[Abstract] [Full Text] [PDF]


Advertisement